ConformationX Therapeutics
Canton, US · Founded 2019 · Delaware LLC
Founders & leadership
TT
Tony TannouryNamed on SEC filing
VC
Vipul ChitaliaNamed on SEC filing
AM
Ali MunawarNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$4.6M disclosed across 1 round · 2019
▶$4.6MraisedJul 2019 · 4 investors · BiotechnologyRule 506(b)
▶$4.6MraisedJul 2019 · 4 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tony TannouryDirector
- Vipul ChitaliaExecutive Officer, Director, Promoter
- Ali MunawarExecutive Officer, Director, Promoter
- Offering amount
- $7M
- Amount sold
- $4.6M
- First sale
- Jun 2019
- Incorporated
- Limited Liability Company, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has ConformationX Therapeutics raised?
- ConformationX Therapeutics has disclosed $4.6M raised across 1 round.
- Where is ConformationX Therapeutics headquartered?
- ConformationX Therapeutics is headquartered in Canton, US.